Tag: Spectranetics
Philips completes acquisition of Spectranetics
Philips has announced that it has completed the acquisition of The Spectranetics Corporation, a US-based global leader in vascular intervention and lead management solutions....
Philips sets sights on Spectranetics, also acquires CardioProlific
Royal Philips and The Spectranetics Corporation announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a...
Positive results for Spectranetics Stellarex demonstrated in ILLUMENATE 12-month data
The final 12-month results of the Stellarex (Spectranetics) drug-coated balloon ILLUMENATE Global Study have found high primary patency and freedom from clinically driven target...